Oxaliplatin and its derivatives–An overview PD O'Dowd, DF Sutcliffe, DM Griffith Coordination Chemistry Reviews 497, 215439, 2023 | 24 | 2023 |
Synthesis and characterisation of a novel mono functionalisable Pt (IV) oxaliplatin-type complex and its peptide conjugate E Kitteringham, AM McKeon, P O'Dowd, M Devocelle, BM Murphy, ... Inorganica Chimica Acta 505, 119492, 2020 | 9 | 2020 |
Comparison of click-capable oxaliplatin and cisplatin derivatives to better understand Pt (ii)-induced nucleolar stress AS Guerrero, PD O’Dowd, HC Pigg, KR Alley, DM Griffith, VJ DeRose RSC Chemical Biology 4 (10), 785-793, 2023 | 4 | 2023 |
A trans-Pt (ii) hedgehog pathway inhibitor complex with cytotoxicity towards breast cancer stem cells and triple negative breast cancer cells AL Ryan, J Northcote-Smith, A McKeon, A Roe, P O'Dowd, B Twamley, ... Dalton Transactions 51 (47), 18127-18135, 2022 | 3 | 2022 |
Click-capable phenanthriplatin derivatives as tools to study Pt (II)-induced nucleolar stress PD O’Dowd, AS Guerrero, KR Alley, HC Pigg, F O’Neill, J Meiller, ... ACS Chemical Biology 19 (4), 875-885, 2024 | 2 | 2024 |
First-in-class metallo-PROTAC as an effective degrader of select Pt-binding proteins PD O’Dowd, GP Sullivan, DA Rodrigues, TN Chonghaile, DM Griffith Chemical Communications 59 (84), 12641-12644, 2023 | 1 | 2023 |